Kyoko Hijiya1, Toyofumi Fengshi Chen-Yoshikawa2, Aya Miyagawa-Hayashino3, Tadakazu Kondo4, Akihiro Aoyama2, Hironori Haga3, Akifumi Takaori-Kondo4, Hiroshi Date2. 1. Department of Thoracic Surgery, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. hijiya@kuhp.kyoto-u.ac.jp. 2. Department of Thoracic Surgery, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. 3. Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan. 4. Department of Hematology and Oncology, Kyoto University Hospital, Kyoto, Japan.
Abstract
PURPOSE: Few studies have investigated pulmonary endothelial chimerism after hematopoietic stem cell transplantation. In the present study, we investigated pulmonary endothelial chimerism using the ABH histo-blood group antigen as an identifying marker in cases of ABO-incompatible hematopoietic stem cell transplantation. METHODS: Sixteen lung samples were analyzed. Of these, seven were explanted lungs from lung transplant recipients with severe pulmonary chronic graft-versus-host disease (GVHD). The remaining nine were autopsy samples from patients who died from various causes, and six of these nine cases had a diagnosis of pulmonary chronic GVHD. The ABH histo-blood group antigen was used to differentiate donor cells from recipient cells immunohistochemically. We estimated the percentage of vessels positive for donor blood group antigens in comparison with the total number of vessels. RESULTS: Donor blood group antigens were expressed in the endothelium of 13 samples, all of which were pathologically diagnosed with pulmonary chronic GVHD. The proportion of vessels with donor group antigens ranged from 0.1 to 17.5%. In contrast, no chimeric vessels were observed in the three samples without pulmonary chronic GVHD. CONCLUSIONS: Our results demonstrate that circulating stem cells engraft into the endothelium to a considerable extent in pulmonary chronic GVHD.
PURPOSE: Few studies have investigated pulmonary endothelial chimerism after hematopoietic stem cell transplantation. In the present study, we investigated pulmonary endothelial chimerism using the ABH histo-blood group antigen as an identifying marker in cases of ABO-incompatible hematopoietic stem cell transplantation. METHODS: Sixteen lung samples were analyzed. Of these, seven were explanted lungs from lung transplant recipients with severe pulmonary chronic graft-versus-host disease (GVHD). The remaining nine were autopsy samples from patients who died from various causes, and six of these nine cases had a diagnosis of pulmonary chronic GVHD. The ABH histo-blood group antigen was used to differentiate donor cells from recipient cells immunohistochemically. We estimated the percentage of vessels positive for donor blood group antigens in comparison with the total number of vessels. RESULTS:Donor blood group antigens were expressed in the endothelium of 13 samples, all of which were pathologically diagnosed with pulmonary chronic GVHD. The proportion of vessels with donor group antigens ranged from 0.1 to 17.5%. In contrast, no chimeric vessels were observed in the three samples without pulmonary chronic GVHD. CONCLUSIONS: Our results demonstrate that circulating stem cells engraft into the endothelium to a considerable extent in pulmonary chronic GVHD.
Authors: F Chen; M Yamane; M Inoue; T Shiraishi; T Oto; M Minami; J Yanagisawa; T Fujinaga; T Shoji; S Toyooka; M Okumura; S Miyoshi; T Bando; H Date Journal: Am J Transplant Date: 2011-06-14 Impact factor: 8.086
Authors: K Weinberg; B R Blazar; J E Wagner; E Agura; B J Hill; M Smogorzewska; R A Koup; M R Betts; R H Collins; D C Douek Journal: Blood Date: 2001-03-01 Impact factor: 22.113
Authors: Mary Eapen; Vanderson Rocha; Guillermo Sanz; Andromachi Scaradavou; Mei-Jie Zhang; William Arcese; Anne Sirvent; Richard E Champlin; Nelson Chao; Adrian P Gee; Luis Isola; Mary J Laughlin; David I Marks; Samir Nabhan; Annalisa Ruggeri; Robert Soiffer; Mary M Horowitz; Eliane Gluckman; John E Wagner Journal: Lancet Oncol Date: 2010-07 Impact factor: 41.316
Authors: S Carlens; O Ringdén; M Remberger; B Lönnqvist; H Hägglund; S Klaesson; J Mattsson; B M Svahn; J Winiarski; P Ljungman; J Aschan Journal: Bone Marrow Transplant Date: 1998-10 Impact factor: 5.483
Authors: Benjamin T Suratt; Carlyne D Cool; Amanda E Serls; Lin Chen; Marileila Varella-Garcia; Elizabeth J Shpall; Kevin K Brown; G Scott Worthen Journal: Am J Respir Crit Care Med Date: 2003-04-30 Impact factor: 21.405
Authors: Barbara C Biedermann; Silvia Sahner; Michael Gregor; Dimitrios A Tsakiris; Christina Jeanneret; Jordan S Pober; Alois Gratwohl Journal: Lancet Date: 2002-06-15 Impact factor: 79.321
Authors: Verena Bröcker; Florian Länger; Tariq G Fellous; Michael Mengel; Mairi Brittan; Martin Bredt; Simone Milde; Tobias Welte; Matthias Eder; Axel Haverich; Malcolm R Alison; Hans Kreipe; Ulrich Lehmann Journal: Am J Respir Crit Care Med Date: 2006-03-09 Impact factor: 21.405